A. Christine Argento, MD
The VeriStrat® blood-based immune profiling test provides a personalized view of each patient’s immune response to their lung cancer and helps inform physicians whether their patient has a more aggressive cancer.
Learn more about:
VeriStrat Good results indicate a disease state that is more likely to respond to standard of care treatment.
VeriStrat Poor results indicate a chronic inflammatory disease state. These patients may benefit from an alternative treatment strategy2,6, including:
Learn how some of the industry’s leading experts are using Biodesix Lung Reflex® testing in their practice.
Froedtert & the Medical College of Wisconsin
Chest Center of the Carolines at FirstHealth of the Carolinas